is tirzepatide a glp 1 agonist Molecular structure of tirzepatide and the dual activation mechanism of GLP-1 Agonist Therapy for Obesity

Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation

In this phenomenon, intramyocellular fat, which accounts for approximately 1.5% in healthy individuals, can rise to 5% in obesity and up to 11% with aging [80]

Neurology 91, e139e142

Lixisenatide is also a short-acting GLP-1 receptor agonist based on the structure of exendin-4 with a half-life of approximately 3 hours [22]

Over six months, that adds up to approximately 82,000 extra calories burned, equivalent to roughly 23 pounds of fat at 3,500 calories per pound

Employees using these medications may benefit from nutrition guidance and working with a Registered Dietitian, adequate protein intake, and strength training support (Reference)